Omega-3 on vascular function in hemodialysis patients
Phase 3
Recruiting
- Conditions
- End stage renal disease (ESRD).End stage renal diseaseN18.6
- Registration Number
- IRCT20220611055142N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Patients with End-stage renal disease undergoing regular hemodialysis
Exclusion Criteria
Age group under 18
Diagnosed with active infection
Diagnosed with severe heart failure
Bilaterally Injured cubital vascular anatomy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The numerical value of flow-mediated vasodilation which is calculated using sonography machine based on percentage. Timepoint: Calculation of flow-mediated vasodilation, once in the beginning of the study (baseline values before initiation of the treatment), and subsequently, three weeks following the continuation of Omega-3 supplementation. Method of measurement: The numerical number will be calculated using sonography machine.
- Secondary Outcome Measures
Name Time Method